| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -11.2% | -16.8% |
| Cost of Revenue | $733K | -15.3% | -23.1% |
| Gross Profit | $843K | -7.3% | -10.4% |
| R&D Expense | $179K | +2.3% | +49.2% |
| SG&A Expense | $724K | +6.9% | +10.5% |
| Operating Income | -$448K | -12.0% | -634.4% |
| Pre-tax Income | -$442K | -12.5% | -750.0% |
| Income Tax | $2K | -33.3% | +0.0% |
| Net Income | -$444K | -12.1% | -722.2% |
| EPS (Basic) | -$0.10 | -11.1% | — |
| EPS (Diluted) | -$0.10 | -11.1% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $264K | +31.3% | — |
| Short-term Investments | $100K | +0.0% | +0.0% |
| Accounts Receivable | $548K | -20.1% | -32.2% |
| Current Assets | $1.3M | -22.0% | -53.2% |
| Total Assets | $2.6M | -12.0% | -35.5% |
| Current Liabilities | $1.2M | +6.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$854K | -49.8% | — |
| Investing Cash Flow | $100K | — | — |
| -17.1% |
| Total Liabilities | $1.2M | +6.6% | -17.1% |
| Stockholders' Equity | $1.4M | -23.4% | -45.8% |